The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
The MLL recombinome of acute leukemias in 2017
Open accessAbstract
Chromosomal rearrangements of the human MLL/KMT2A gene are associated with infant, pediatric, adult and therapy-induced acute leukemias. Here we present the data obtained from 2345 acute leukemia patients. Genomic breakpoints within the MLL gene and the involved translocation partner genes (TPGs) were determined and 11 novel TPGs were identified. Thus, a total of 135 different MLL rearrangements have been identified so far, of which 94 TPGs are now characterized at the molecular level. In all, 35 out of these 94 TPGs occur recurrently, but only 9 specific gene fusions account for more than 90% of all illegitimate recombinations of the MLL gene. We observed an age-dependent breakpoint shift with breakpoints localizing within MLL intron 11 associated with acute lymphoblastic leukemia and younger patients, while breakpoints in MLL intron 9 predominate in AML or older patients. The molecular characterization of MLL breakpoints suggests different etiologies in the different age groups and allows the correlation of functional domains of the MLL gene with clinical outcome. This study provides a comprehensive analysis of the MLL recombinome in acute leukemia and demonstrates that the establishment of patient-specific chromosomal fusion sites allows the design of specific PCR primers for minimal residual disease analyses for all patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,530
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
hDOT1L Links Histone Methylation to Leukemogenesis
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 804
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Krivtsov, A. V., Feng, Z., Lemieux, M. E., Faber, J., Vempati, S., Sinha, A. U., Xia, X., Jesneck, J., Bracken, A. P., Silverman, L. B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.001 · Cited by 550
The MLL recombinome of acute leukemias in 2013
Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., et al. (2013) · Leukemia · doi:10.1038/leu.2013.135 · Cited by 491
Self-citationBalgobind, B. V., Raimondi, S. C., Harbott, J., Zimmermann, M., Alonzo, T. A., Auvrignon, A., Beverloo, H. B., Chang, M., Creutzig, U., Dworzak, M. N., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215152 · Cited by 445
Self-citationNew insights to the MLL recombinome of acute leukemias
Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Ben Abdelali, R., Macintyre, E., De Braekeleer, E., De Braekeleer, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.33 · Cited by 407
Self-citationPui, C.-H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A., Kamps, W., Silverman, L. B., Biondi, A., Harms, D. O., Vilmer, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08782-2 · Cited by 399
Self-citationBitoun, E., Oliver, P. L., & Davies, K. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl444 · Cited by 312
Ma, Z., Morris, S. W., Valentine, V., L, M., Herbrick, J.-A., Cui, X., Bouman, D., Li, Y., Mehta, P. K., Nizetic, D., et al. (2001) · Nature Genetics · doi:10.1038/90054 · Cited by 304
The MLL recombinome of acute leukemias
Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M. W. J. C., van Dongen, J. J. M., den Boer, M. L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404150 · Cited by 271
Self-citationClinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
Pui, C.-H., Chessells, J. M., Camitta, B., Baruchel, A., Biondi, A., Boyett, J. M., Carroll, A., Eden, O. B., Evans, W. E., Gadner, H., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402883 · Cited by 241
Self-citationWang, Z., Song, J., Milne, T. A., Wang, G. G., Li, H., Allis, C. D., & Patel, D. J. (2010) · Cell · doi:10.1016/j.cell.2010.05.016 · Cited by 201
A Novel 4EHP-GIGYF2 Translational Repressor Complex Is Essential for Mammalian Development
Morita, M., Ler, L. W., Fabian, M. R., Siddiqui, N., Mullin, M., Henderson, V. C., Alain, T., Fonseca, B. D., Karashchuk, G., Bennett, C. F., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00455-12 · Cited by 198
Xia, Z.-B., Anderson, M., Diaz, M. O., & Zeleznik-Le, N. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1436338100 · Cited by 194
Leukemias related to treatment with DNA topoisomerase II inhibitors*
Felix, C. A. (2001) · Medical and Pediatric Oncology · doi:10.1002/mpo.1125 · Cited by 191
Diagnostic tool for the identification of MLL rearrangements including unknown partner genes
Meyer, C., Schneider, B., Reichel, M., Angermueller, S., Strehl, S., Schnittger, S., Schoch, C., Jansen, M. W. J. C., van Dongen, J. J., Pieters, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406994102 · Cited by 180
Self-citationStanulla, M., Wang, J., Chervinsky, D. S., Thandla, S., & Aplan, P. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4070 · Cited by 178
Self-citationWilkinson, A. C., Ballabio, E., Geng, H., North, P. S., Tapia, M. C., Kerry, J., Biswas, D., Roeder, R. G., Allis, C. D., Melnick, A. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.016 · Cited by 163
The AF4·MLL fusion protein is capable of inducing ALL in mice without requirement of MLL·AF4
Bursen, A., Schwabe, K., Rüster, B., et al. (2010) · Blood · doi:10.1182/blood-2009-06-229542 · Cited by 150
Strissel, P. L., Strick, R., Rowley, J. D., & Zeleznik‐Le, N. J. (1998) · Blood · doi:10.1182/blood.v92.10.3793 · Cited by 150
Harrison, C. J., Moorman, A. V., Barber, K. E., Broadfield, Z. J., Cheung, K. L., Harris, R. L., Jalali, G. R., Robinson, H. M., Strefford, J. C., Stewart, A. R. M., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05497.x · Cited by 148
Protein Interactions of the MLL PHD Fingers Modulate MLL Target Gene Regulation in Human Cells
Fair, K., Anderson, M., Bulanova, E., Mi, H., Tropschug, M., & Dı́az, M. O. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3589-3597.2001 · Cited by 143
Yeoh, A. E. J., Ariffin, H., Chai, E. L. L., Kwok, C. S. N., Chan, Y. H., Kuperan, P., Campana, D., Tan, P. L., Chan, M. Y., Kham, S. K. Y., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.5936 · Cited by 135
The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis
Daser, A., & Rabbitts, T. H. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.007 · Cited by 131
Binding of the MLL PHD3 Finger to Histone H3K4me3 Is Required for MLL-Dependent Gene Transcription
Chang, P.-Y., Hom, R. A., Musselman, C. A., Zhu, L., Kuo, A. J., Gozani, O., Kutateladze, T. G., & Cleary, M. L. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.005 · Cited by 109
Genetic aberrations in paediatric acute leukaemias and implications for management of patients
Szczepański, T., Harrison, C. J., & van Dongen, J. J. M. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70369-9 · Cited by 102
Self-citationA role for the Rab6A′ GTPase in the inactivation of the Mad2‐spindle checkpoint
Miserey‐Lenkei, S., Couëdel-Courteille, A., Nery, E. D., Bardin, S., Piel, M., Racine, V., Sibarita, J., Perez, F., Bornens, M., & Goud, B. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600929 · Cited by 89
Versatility at the nuclear pore complex: lessons learned from the nucleoporin Nup153
Ball, J. R., & Ullman, K. S. (2005) · Chromosoma · doi:10.1007/s00412-005-0019-3 · Cited by 82
Bursen, A., Moritz, S., Anne, G., Moritz, S., Dingermann, T., & Marschalek, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207837 · Cited by 79
Self-citationSplit-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia
van der Burg, M., Poulsen, T. S., Hunger, S. P., Beverloo, H. B., Smit, E. M. E., Vang-Nielsen, K., Langerak, A. W., & van Dongen, J. J. M. (2004) · Leukemia · doi:10.1038/sj.leu.2403340 · Cited by 73
Marschalek, R. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2016.36.2.85 · Cited by 71
Self-citationTCF12 is mutated in anaplastic oligodendroglioma
Labrèche, K., Simeonova, I., Kamoun, A., Gleize, V., Chubb, D., Letouzé, É., Riazalhosseini, Y., Dobbins, S. E., Elarouci, N., Ducray, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8207 · Cited by 65
Burmeister, T., Marschalek, R., Schneider, B., Meyer, C., Gökbuget, N., Schwartz, S., Hoelzer, D. T., & Thiel, E. (2006) · Leukemia · doi:10.1038/sj.leu.2404082 · Cited by 64
Self-citationYi, S., Yu, M., Yang, S., Miron, R. J., & Zhang, Y. (2016) · Stem Cells · doi:10.1002/stem.2491 · Cited by 64
ECSASB2 mediates MLL degradation during hematopoietic differentiation
Wang, J., Muntean, A. G., & Hess, J. L. (2011) · Blood · doi:10.1182/blood-2011-06-362079 · Cited by 57
Cep55 regulates spindle organization and cell cycle progression in meiotic oocyte
Xu, Z.-Y., Ma, X., Qi, S., Wang, Z., Guo, L., Schatten, H., Sun, Q., & Sun, Y. (2015) · Scientific Reports · doi:10.1038/srep16978 · Cited by 57
Scharf, S., Zech, J., Bursen, A., Schraets, D., Oliver, P. L., Kliem, S., Pfitzner, E., Gillert, E., Dingermann, T., & Marschalek, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209948 · Cited by 54
Self-citationTTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation
Watanabe, T., Kakeno, M., Matsui, T., Sugiyama, I., Arimura, N., Matsuzawa, K., Shirahige, A., Ishidate, F., Nishioka, T., Taya, S., et al. (2015) · The Journal of Cell Biology · doi:10.1083/jcb.201412075 · Cited by 54
Majeed, S. R., Vasudevan, L., Chen, C., Luo, Y., Torres, J. A., Evans, T. M., Sharkey, A., Foraker, A. B., Wong, N. M. L., Esk, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4891 · Cited by 52
CLIP2 as radiation biomarker in papillary thyroid carcinoma
Selmansberger, M., Feuchtinger, A., Zurnadzhy, L., Michna, A., Kaiser, J. C., Abend, M., Brenner, A. V., Ti, B., Walch, A. K., Unger, K., et al. (2014) · Oncogene · doi:10.1038/onc.2014.311 · Cited by 51
Kim, M., Semple, I. A., Kim, B. Y., Kiers, A., Nam, S., Park, H., Park, H., Ro, S., Kim, J.-S., Juhász, G., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1063766 · Cited by 49
A Subset of Mixed Lineage Leukemia Proteins Has Plant Homeodomain (PHD)-mediated E3 Ligase Activity
Wang, J., Muntean, A. G., Wu, L., & Hess, J. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423855 · Cited by 49
CLTC as a clinically novel gene associated with multiple malformations and developmental delay
DeMari, J. A., Mroske, C., Tang, S., Nimeh, J., Miller, R., & Lebel, R. R. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37506 · Cited by 49
Braunstein, M., & Anderson, M. K. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/678705 · Cited by 41
Recurrent KIF2A mutations are responsible for classic lissencephaly
Cavallin, M., Bijlsma, E. K., Elmorjani, A., Moutton, S., Peeters, E. A. J., Maillard, C., Pedespan, J. M., Guerrot, A., Drouin‐Garraud, V., Coubes, C., et al. (2016) · Neurogenetics · doi:10.1007/s10048-016-0499-8 · Cited by 39
Kif2a regulates spindle organization and cell cycle progression in meiotic oocytes
Yi, Z., Ma, X., Liang, Q., Zhang, T., Xu, Z.-Y., Meng, T., Ouyang, Y., Hou, Y., Schatten, H., Sun, Q., et al. (2016) · Scientific Reports · doi:10.1038/srep38574 · Cited by 36
CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells
Jafari, N., Kim, H.-J., Park, R., Li, L., Jang, M., Morris, A. J., Park, J., & Huang, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170327 · Cited by 35
Abnormal Expression of PFDN4 in Colorectal Cancer: A Novel Marker for Prognosis
Miyoshi, N., Ishii, H., Mimori, K., Nishida, N., Tokuoka, M., Akita, H., Sekimoto, M., Doki, Y., & Mori, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1138-5 · Cited by 32
KIF2A regulates the spindle assembly and the metaphase I-anaphase I transition in mouse oocyte
Chen, M.-H., Liu, Y., Wang, Y., Liu, R. R., Xu, B., Zhang, F., Li, F.-P., Xu, L., Lin, Y., He, S., et al. (2016) · Scientific Reports · doi:10.1038/srep39337 · Cited by 23
Post-transcriptional gene silencing activity of human GIGYF2
Kryszke, M.-H., Adjeriou, B., Liang, F., Chen, H., & Dautry, F. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.022 · Cited by 22
Flipping MLL1's Switch One Proline at a Time
Grow, E. J., & Wysocka, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.013 · Cited by 16
Cited by
Krivtsov, A. V., Evans, K., Gadrey, J. Y., Eschle, B. K., Hatton, C., Uckelmann, H. J., Ross, K. N., Perner, F., Olsen, S. N., Pritchard, T., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.11.001 · Cited by 447
The language of chromatin modification in human cancers
Zhao, S., Allis, C. D., & Wang, G. G. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00357-x · Cited by 402
Pieters, R., De Lorenzo, P., Ancliffe, P., Aversa, L. A., Brethon, B., Biondi, A., Campbell, M., Escherich, G., Ferster, A., Gardner, R. A., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00261 · Cited by 297
Self-citationFOXO transcription factor family in cancer and metastasis
Jiramongkol, Y., & Lam, E. W.-F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09883-w · Cited by 281
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
on behalf of the International CML Foundation Genomics Alliance, Branford, S., Kim, D. D. H., Apperley, J. F., Eide, C. A., Mustjoki, S., Ong, S. T., Nteliopoulos, G., Ernst, T., Chuah, C., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0512-y · Cited by 149
Metadata
- Authors
- Meyer, C., Burmeister, T., Gröger, D., Tsaur, G., Fechina, L., Renneville, A., Sutton, R., Venn, N. C., Emerenciano, M., Pombo-de-Oliveira, M. S., Barbieri Blunck, C., Almeida Lopes, B., Zuna, J., Trka, J., Ballerini, P., Lapillonne, H., De Braekeleer, M., Cazzaniga, G., Corral Abascal, L., van der Velden, V. H. J., Delabesse, E., Park, T. S., Oh, S. H., Silva, M. L. M., Lund-Aho, T., Juvonen, V, Moore, A. S., Heidenreich, O., Vormoor, J., Zerkalenkova, E., Olshanskaya, Y., Bueno, C., Menendez, P., Teigler-Schlegel, A., zur Stadt, U., Lentes, J., Göhring, G., Kustanovich, A., Aleinikova, O., Schäfer, B. W., Kubetzko, S., Madsen, H. O., Gruhn, B., Duarte, X., Gameiro, P., Lippert, E., Bidet, A., Cayuela, J. M., Clappier, E., Alonso, C. N., Zwaan, C. M., van den Heuvel-Eibrink, M. M., Izraeli, S., Trakhtenbrot, L., Archer, P., Hancock, J., Möricke, A., Alten, J., Schrappe, M., Stanulla, M., Strehl, S., Attarbaschi, A., Dworzak, M., Haas, O. A., Panzer-Grümayer, R., Sedék, L., Szczepański, T., Caye, A., Suarez, L., Cavé, H., & Marschalek, R.
- Venue
- Leukemia
- Published
- 2017-07-13
- Volume
- 32
- Issue
- 2
- Pages
- 273-284
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2916162780
- Cited by
- 676
- References
- 53
- FWCI
- 41.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.